Scientists probe why older skin turns cancerous
NCT ID NCT02553954
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at healthy skin tissue from 58 people with sarcoma to understand how aging changes cells and may increase cancer risk. Researchers compare skin from younger adults (18-40) and older adults (55+) to find markers of aging. The goal is to learn why certain skin cancers become more common with age.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help explain why skin cancer risk increases with age and point to new ways to prevent it.
- What could go wrong
- This is a small, early-stage observational study, not a treatment trial. It may not lead to any direct medical advances.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
58 people
The number who actually took part.
- Started
-
Oct 2014
- Finished
-
Apr 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient with an operable sarcoma * Requiring a surgical operation under general anesthesia at the Oscar Lambret Centre * Age ≥ 18 ans, belonging to one of the two following age groups : \[ ≥ 18 and ≤ 40 years\] and \[ ≥ 55 years\] * Patient having a social security scheme * Patient having signed an informed consent form for the study Exclusion Criteria: * Patient aged under 18 or between 41 and 54 * Location of the tumor on the face, neck or neckline * Patient with a skin tumor * Tumor-induced cutaneous fistula making suspect a tumor invasion of the skin * Patient with a chronic skin disease * Collection in an area already treated by surgery, radiotherapy or brachytherapy * Pregnant or breastfeeding women * Patient under guardianship or tutorship
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sarcoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Oscar Lambret
Lille, 59020, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Blood-Flow-Blocking drug stall a rare sarcoma?
- Can a new drug shrink advanced solid tumors?
- Can a coordinated care team reduce severe side effects in older cancer patients?
- Can repeated MRI scans reveal how tumors respond to radiation?
- Can a new antibody help the immune system fight Hard-to-Treat tumors?
- Pedaling through chemo: could exercise boost tumor blood flow?